Litcius/Paper detail

Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma

Yunze Xu, Wen Kong, Ming Cao, Jieying Wang, Zaoyu Wang, Liang Zheng, Xiaoyu Wu, Rongrong Cheng, Wei He, Bo Yang, Baijun Dong, Jiahua Pan, Yonghui Chen, Jiwei Huang, Chen Jiang, Wei Zhai, Fangzhou Li, Ruohua Chen, Xiang Zhou, Guangyu Wu, Xiaochuan Geng, Jiasheng Chen, Huimin An, Yichu Yuan, Tianyuan Xu, Dongning Chen, Dengqiang Lin, Lieyu Xu, Kangbo Huang, Ling Peng, Yanfei Yu, Shengcheng Tai, Honggang Qi, Kai Luo, Xiaonan Kang, Hang Wang, Yiran Huang, Jin Zhang, Wei Xue

2022European Urology55 citationsDOI

Topics & Concepts

MedicineInternal medicineHazard ratioOncologyRenal cell carcinomaResponse Evaluation Criteria in Solid TumorsTyrosine-kinase inhibitorGastroenterologyProgressive diseaseCancerConfidence intervalChemotherapyRenal cell carcinoma treatmentBladder and Urothelial Cancer TreatmentsTuberous Sclerosis Complex Research
Genomic Profiling and Response to Immune Checkpoint Inhibition plus Tyrosine Kinase Inhibition in FH-Deficient Renal Cell Carcinoma | Litcius